Charité Research Organisation GmbH

🇩🇪Germany

Country: 🇩🇪Germany

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat

Phase 2

Terminated

Conditions: Covid19

Interventions: Drug: Niclosamide + Camostat
Other: Placebo

First Posted Date: 2021-02-11

Last Posted Date: 2021-12-09

Lead Sponsor: Charité Research Organisation GmbH

Target Recruit Count: 4

Registration Number: NCT04750759

Locations: 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany

Safety and Pharmacokinetics of a Novel Niclosamide Solution in Combination With Camostat

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Placebo
Drug: Niclosamide

First Posted Date: 2020-11-25

Last Posted Date: 2021-11-29

Lead Sponsor: Charité Research Organisation GmbH

Target Recruit Count: 28

Registration Number: NCT04644705

Locations: 🇩🇪
Charité Research Organisation GmbH, Berlin, Germany

Prev
1
Next

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy